Wellington Management Group
TVTX icon

Wellington Management Group’s Travere Therapeutics TVTX Stock Holding History

Wellington Management Group’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.1M Buy
1,533,080
+510,808
+50% +$22.6M 0.02% 583
2026
Q1 		$30.4M Buy
1,022,272
+223,288
+28% +$6.67M 0.01% 878
2025
Q4 		$30.5M Sell
798,984
-402,485
-33% -$13.1M 0.01% 883
2025
Q3 		$28.7M Buy
1,201,469
+1,166,460
+3,332% +$21.9M 0.01% 896
2025
Q2 		$518K Buy
35,009
+1,839
+6% +$30.5K ﹤0.01% 1817
2025
Q1 		$594K Sell
33,170
-323
-1% -$6.55K ﹤0.01% 1796
2024
Q4 		$583K Buy
+33,493
New +$592K ﹤0.01% 1810
2024
Q3 		– Sell
-72,658
Closed -$597K – 2027
2024
Q2 		$597K Buy
72,658
+17,088
+31% +$115K ﹤0.01% 1762
2024
Q1 		$428K Sell
55,570
-86,424
-61% -$729K ﹤0.01% 1823
2023
Q4 		$1.28M Buy
+141,994
New +$1.03M ﹤0.01% 1575
2018
Q4 		– Sell
-33,902
Closed -$974K – 2204
2018
Q3 		$974K Buy
33,902
+1,501
+5% +$42.9K ﹤0.01% 1883
2018
Q2 		$883K Buy
32,401
+22,658
+233% +$603K ﹤0.01% 1917
2018
Q1 		$218K Hold
9,743
– – ﹤0.01% 2150
2017
Q4 		$205K Buy
+9,743
New +$223K ﹤0.01% 2178

Other funds holding TVTX

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group's TVTX Position: Q2 2026 in Review

Wellington Management Group increased its Travere Therapeutics (TVTX) stake by 50% in Q2 2026, buying an estimated $22.6M and bringing the position to 1,533,080 shares worth $87.1M. The position accounts for 0.02% of the portfolio, ranked #583.

Wellington Management Group first reported a position in TVTX in Q4 2017 and has held it in 14 quarters since. 320 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

  • Wellington Management Group held 1,533,080 shares of Travere Therapeutics worth $87.1M as of Q2 2026.
  • Wellington Management Group bought 510,808 Travere Therapeutics shares in Q2 2026, an estimated $22.6M.
  • Travere Therapeutics made up 0.02% of Wellington Management Group's portfolio in Q2 2026, its #583 holding.
  • Wellington Management Group first reported a position in Travere Therapeutics in Q4 2017 and has held it in 14 quarters since.
  • 320 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.